Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Salamanca (25)

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  3. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894

  2. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

    International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336

  3. Genetically determined telomere length and multiple myeloma risk and outcome

    Blood Cancer Journal, Vol. 11, Núm. 4

  4. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

2020

  1. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7

  2. Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis

    Infection and Immunity, Vol. 88, Núm. 4

2019

  1. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

  2. Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Leukemia and Lymphoma, Vol. 60, Núm. 7, pp. 1803-1811

2017

  1. Identification of miRSNPs associated with the risk of multiple myeloma

    International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534

2016

  1. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis

    Oncotarget, Vol. 7, Núm. 37, pp. 59029-59048

  2. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis

    Frontiers in Microbiology, Vol. 7, Núm. AUG

  3. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium

    Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657

2015

  1. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E351-E358

  2. Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium

    Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559

2014

  1. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations - An extensive replication of the associations from the candidate gene era

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 4, pp. 670-674

2013

  1. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: A case-control study in the context of the IMMEnSE consortium

    Journal of Human Genetics, Vol. 58, Núm. 3, pp. 155-159